open access
Vol 10, No 4 (2009): Practical Diabetology
Other materials agreed with the Editors
Submitted: 2012-01-02
Published online: 2009-11-05
Get Citation
Early and aggressive initiation of insulin therapy for type 2 diabetes: what is the evidence?
Diabetologia Praktyczna 2009;10(4):162-172.
open access
Vol 10, No 4 (2009): Practical Diabetology
Review articles (translated)
Submitted: 2012-01-02
Published online: 2009-11-05
Abstract
Type 2 diabetes is a progressive disease in which beta-cell function continually declines and eventually
fails, ultimately requiring nearly all patients to be
placed on insulin therapy. An increasing body of evidence
suggests that early intensive glycemic ontrol
reduces long-term vascular outcomes and potentially
may prolong beta-cell lifespan and function. Herein,
evidence in favor of early insulin therapy on disease progression and long-term outcomes will be reviewed
and placed into clinical context.
Abstract
Type 2 diabetes is a progressive disease in which beta-cell function continually declines and eventually
fails, ultimately requiring nearly all patients to be
placed on insulin therapy. An increasing body of evidence
suggests that early intensive glycemic ontrol
reduces long-term vascular outcomes and potentially
may prolong beta-cell lifespan and function. Herein,
evidence in favor of early insulin therapy on disease progression and long-term outcomes will be reviewed
and placed into clinical context.
Get Citation
About this articleTitle
Early and aggressive initiation of insulin therapy for type 2 diabetes: what is the evidence?
Journal
Issue
Vol 10, No 4 (2009): Practical Diabetology
Article type
Other materials agreed with the Editors
Pages
162-172
Published online
2009-11-05
Page views
602
Article views/downloads
3528
Bibliographic record
Diabetologia Praktyczna 2009;10(4):162-172.
Authors
Kelvin Niswender